Next Quarterly Earnings
Thursday, November 5, 2026
Expected
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is a US-based biopharmaceutical company developing innovative medicines for rare endocrine diseases. The company focuses on therapies that improve hormone balance for patients with severe, underserved conditions. Crinetics Pharmaceuticals advances its pipeline through cutting-edge research and clinical trials, aiming to address unmet medical needs in endocrinology.
Frequently asked questions
When did Crinetics Pharmaceuticals last report quarterly earnings?
Crinetics Pharmaceuticals last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -1.14 USD.
How often has Crinetics Pharmaceuticals beaten expectations?
Crinetics Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Crinetics Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+1.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Crinetics Pharmaceuticals
Country
🇺🇸
More Financial Information